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Introduction {#sec1}
============

The growth cone, a specialized, highly motile structure formed at the tips of extending axons of developing neurons ([@bib12], [@bib29]), is crucial for accurate synaptogenesis in the developing brain. In addition, growth cone activity is involved in the rearrangement of neuronal networks during neural plasticity and axonal regeneration in the adult brain ([@bib5], [@bib17], [@bib38], [@bib48]). Therefore, to understand the mechanisms underlying neuronal network formation and maintenance, it is essential to elucidate the molecular pathways that determine growth cone behavior. At present, however, little molecular information is available regarding growth cones in the mammalian brain. Previously, we performed a proteomics analysis of mammalian growth cones and characterized approximately 1,000 unique proteins ([@bib40]; see also [@bib14]). The results of this analysis revealed novel molecular mechanisms underlying nerve growth ([@bib29], [@bib39], [@bib23], [@bib24]).

To further investigate molecular signaling in growth cones, we focused on protein phosphorylation, the most important regulatory mechanism in many cellular processes ([@bib26]). To date, most efforts in this regard have used *in vitro* phosphorylation systems that do not necessarily represent the *in vivo* situation. Phosphoproteomics is an important, novel, and powerful technique for comprehensive and quantitative identification of *in vivo* phosphorylation sites ([@bib51]) and should be able to establish novel molecular markers for axonal growth and regeneration.

Specifically, we performed phosphoproteomics analysis of the growth cone membrane (GCM; [@bib59], [@bib40], [@bib29]). From among more than 30,000 phosphopeptides, this analysis identified ∼4,600 different phosphorylation sites from ∼1,200 proteins. Surprisingly, proline (P)-directed phosphorylation was predominant, with more than 60% of serine (S) or threonine (T) phosphorylation sites predicted to depend on P-directed kinases. Bioinformatics analysis suggested that these frequent P-directed phosphorylation events were due to mitogen-activated protein kinase (MAPK) activation. In particular, we found that c-Jun *N*-terminus kinase (JNK; [@bib6]) was the major active member of the MAPK family and was responsible for several heavily phosphorylated sites.

The most abundant phosphorylated site was S96 of *neuronal growth-associated 43-kDa* (GAP-43, also called as neuromodulin), a vertebrate neuron-specific protein involved in nerve growth ([@bib46], [@bib11], [@bib22]), comprising more than 1% of all phosphopeptides. This phosphorylated site was previously uncharacterized. Subsequent experiments revealed that S96 phosphorylation (pS96) was JNK dependent. A pS96 antibody (Ab) specifically recognized growing and regenerating axons, and pS96 was directly detected in regenerating axons by mass spectrometry (MS).

Taken together, our data show that JNK signaling is a key pathway for axon growth that is conserved across a wide range of animals. JNK signaling via vertebrate-specific substrates such as GAP-43 plays important roles in mammalian growth cones, and pS96 Ab represents a promising new molecular marker for mammalian axonal growth/regeneration.

Results {#sec2}
=======

High Frequency of P-Directed Phosphosites in GCMs {#sec2.1}
-------------------------------------------------

Phosphoproteomics analysis of GCM fractions isolated from postnatal day 1 (P1) rat forebrain identified more than 30,000 phosphopeptides at greater than 95% confidence (see [Data S1](#mmc2){ref-type="supplementary-material"}). The condensation ratio of the phosphopeptides (i.e., the ratio of phosphopeptides to total peptides) was 95.9%. Thresholding with 1% false discovery rate (FDR) extracted 4,596 phosphorylation sites that corresponded to 1,223 proteins. Highly frequent phosphorylation sites are shown in [Table S1](#mmc1){ref-type="supplementary-material"}.

We classified the kinase substrates in GCMs into various categories based on the number of phosphorylation sites ([Figure 1](#fig1){ref-type="fig"}A) and the frequency of phosphopeptides phosphorylated at S or T ([Figure 1](#fig1){ref-type="fig"}B). Cytoskeletal components and signaling proteins were the major GCM phosphoproteins identified in this manner ([Figures 1](#fig1){ref-type="fig"}A and 1B; see also [Data S2](#mmc3){ref-type="supplementary-material"}, referring to the protein names). Among the phosphopeptides identified in GCMs, serine-proline (SP)/threonine-proline (TP) residues, i.e., P-directed-kinase-dependent phosphorylation sites ([@bib50], [@bib28]), were highly enriched in the GCM ([Figures 1](#fig1){ref-type="fig"}B, [2](#fig2){ref-type="fig"}A, and 2B; [Table S1](#mmc1){ref-type="supplementary-material"}).Figure 1GCM Phosphopeptides Derived from P1 Rat Brain Reveal a Large Number of P-Directed Kinase Substrates(A) Classification of phosphoproteins (1,223 proteins in total) that were derived from the phosphopeptides (4,596 species) detected by MS with 1% FDR. The value in each row represents the fraction of proteins in each functional category.(B) Counts of peptides phosphorylated at serine (28,987 total counts) and threonine (4,068 total counts) that belong to each protein category. The counts were further divided into those for P-directed sites (*filled bars*) and those for non-P-directed sites (*open bars*).Figure 2Bioinformatics Analysis of Phosphosites Identified by GCM Phosphoproteomics of Rat P1 Brain Reveals that P-Directed Sites Are Mainly Dependent on MAPK(A and B) Fractions of phosphosites (*left*) and phosphopeptides (*right*) that are substrates of acid, basic, and proline-directed kinases for all data (A) or data thresholded by 20 counts (B).(C) Protein kinases predicted for the serine (*left*) and threonine (*right*) phosphosites using KinasePhos server. The value in each row represents the fraction of phosphopeptides that are the targets of each kinase. The fractions were further divided into P-directed (*filled bars*) or non-P-directed (*open bars*) phosphorylation.(D) Protein association network for P-directed and non-P-directed proteins. Protein association network was constructed using the STRING database ([@bib60]), merged with data from human, rat, and mouse. *Red* and *green* filled circles indicate P-directed and non-P-directed phosphorylated proteins, respectively. The size of the circle for each protein represents its phosphorylation frequency in GCM. The colors of the external rings indicate enriched protein network groups: group I (*red*), cytoskeletal proteins (microtubule-related proteins, cortical skeletal proteins, and actin-binding proteins); group II (*yellow*), signaling molecules related to axon growth/guidance (cell adhesion molecules, proteins in cAMP- or Ca^2+^-dependent signaling pathways, small GTPase signaling molecules, and guidance receptors); and group III (*blue*), other categories. Proteins without the external rings were not enriched.

Protein kinases are classified into four major groups: acidic, basic, P directed, and others ([@bib50]). P-directed sites constituted 63.9% of phosphoserine (pS) and 78.0% of phosphothreonine (pT) sites in all categories ([Figure 1](#fig1){ref-type="fig"}B; [Data S1](#mmc2){ref-type="supplementary-material"}). The typical sequences of each protein kinase category were visualized using the *IceLogo* web server ([Figure S1](#mmc1){ref-type="supplementary-material"}). The fraction of P-directed sites ([Figures 2](#fig2){ref-type="fig"}A and 2B) was higher than those estimated from a meta-analysis of two previous reports on phosphoproteomics ([@bib33], [@bib27]; [Figure S2](#mmc1){ref-type="supplementary-material"}).

Next, we predicted kinases that are responsible for the phosphorylation sites identified by our analysis. Using a kinase-specific phosphorylation site prediction tool KinasePhos ([@bib25], [@bib52]), we found that MAPK is most likely to be a kinase responsible for the phosphorylation of SP/TP sites with high frequencies ([Figure 2](#fig2){ref-type="fig"}C). To elucidate the physiological functions of these substrates, we performed enrichment analysis using the GCM phosphorylation data, particularly for phosphopeptides that were phosphorylated ≥20 times ([Figure 2](#fig2){ref-type="fig"}B; [Data S3](#mmc4){ref-type="supplementary-material"}). Two groups containing such highly phosphorylated sites, cytoskeleton-associated proteins (group I) and signaling proteins including cell adhesion molecules and guidance receptors (group II), were also highly enriched in the protein networks ([Figure 2](#fig2){ref-type="fig"}D). Substrates with P-directed phosphorylated sites ([Figure 2](#fig2){ref-type="fig"}C) were also enriched ([Figure 2](#fig2){ref-type="fig"}D). These proteins are thought to be involved in axon growth and guidance in mammalian brain ([@bib12], [@bib29], [@bib45], [@bib4]). Therefore, our results suggest that highly concentrated P-directed phosphoproteins in GCM play important functional roles in mammalian axon growth and guidance.

P-Directed Phosphorylation of GCM Phosphoproteins Requires JNK Activity {#sec2.2}
-----------------------------------------------------------------------

The MAPK family includes extracellular-signal-regulated kinase (ERK), p38, and JNK, among which JNK appeared to be the most likely kinase candidate for mammalian GCM phosphorylation. First, several recent reports showed that JNK is involved in multiple steps of mammalian brain development ([@bib41], [@bib21], [@bib3], [@bib9]). Second, JNK signaling is activated during axon regeneration, even in *C. elegans* ([@bib37]). Together, these observations suggest the importance of JNK signaling in a wide range of organisms.

To test this hypothesis, we produced eight phospho-specific Abs against the high-frequency SP/TP phosphorylation sites (total number = 1,163, corresponding to 3.8% of the Conf95 phosphopeptides; [Figure 3](#fig3){ref-type="fig"}A; see also [Tables S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"}). The most frequently phosphorylated site was S96 of GAP-43. When we chemically inhibited MAPK family members, only the JNK inhibitor SP600125 specifically blocked phosphorylation of GAP-43, as determined using phospho-specific Abs ([Figures 3](#fig3){ref-type="fig"}A and [S3](#mmc1){ref-type="supplementary-material"}A; the antigen sequences are shown in [Table S2](#mmc1){ref-type="supplementary-material"}). The intensities of two sites in GAP-43, S96 and T172, were decreased by SP600125 treatment ([Figure 3](#fig3){ref-type="fig"}B).Figure 3MAPK Substrates Identified by GCM Phosphoproteomics Undergo JNK-Dependent Phosphorylation(A and B) Mouse cortical neurons were treated with 20 μM SP600125 (JNK inhibitor), 5 μM U0126 (MEK1/2 inhibitor), or 5 μM SB203580 (p38 inhibitor) for 3 hr. As a control, an equal volume of the solvent DMSO was added to the medium. (A) The SP/TP phosphorylated sites of various GCM proteins are JNK dependent. Frequencies not appearing in [Table S1](#mmc1){ref-type="supplementary-material"} are as follows: Robo2 \[pT1154\] = 25; GAP-43 \[pS142\] = 18; and Rufy3 \[pT5\] = 19. Western blot results of non-phosphospecific Abs are shown as negative controls. Kinase inhibitors did not affect the reactivity of any of these non-phosphospecific Abs. (B) Effects of MAPK inhibitors on GAP-43 phosphorylation at S96 and T172. Values represent the measured intensity (mean ± SEM, n = 3). \*\*p \< 0.01; \*p \< 0.05; ns, p \> 0.05. One-way repeated measures ANOVA with Bonferroni tests to the control.(C) Brain-specific cKO of MKK7 ([@bib53]), an upstream activator of JNK, suppressed the identified SP/TP phosphorylation. Brain extracts from WT and MKK7^flox/flox^ Nestin-Cre embryos at E15.5 were analyzed by immunoblotting using the indicated Abs. Western blot results of non-phosphospecific Abs are shown as the controls. Kinase inhibitors did not affect the reactivity of any of these non-phosphospecific Abs.(D and E) Effects of mouse JNK knock down on GAP-43 pS96 and pT172. The representative western blotting (D) and quantified (E) data. Values represent the measured intensity (mean ± SEM, n = 3). \*p \< 0.05; ns, p \> 0.05. One-way ANOVA with Bonferroni tests to the control. *GAPDH: glyceroaldehyde-3-phosphate dehydrogenase* (A, C, and D).

We also identified the upstream signal that activates JNK. In the brain, MKK7 is a specific activator of JNK ([@bib53]), and mice with brain-specific conditional knockout (cKO) of MKK7 exhibit hypoactive axon formation in the developing brain ([@bib53], [@bib55]). Using our phospho-specific Abs in this cKO mouse, we found that phosphorylation signals in the brain were greatly diminished, as also observed with the chemical inhibitor ([Figure 3](#fig3){ref-type="fig"}C). By contrast, cyclin-dependent kinase 5 (CDK5) and glycogen synthase kinase 3β (GSK3β) inhibitors did not prevent GAP-43 phosphorylation, suggesting that neither of these kinases is responsible for S96 or T172 phosphorylation ([Figures S3](#mmc1){ref-type="supplementary-material"}B and S3C).

JNK has three isoforms: JNK1, JNK2, and JNK3 ([@bib18], [@bib9]). Because JNK3 is not involved in early brain development ([@bib30]) and its expression is lower than that of the other two, we did not investigate its role in these experiments. Treatment of the cultured cortical neurons with small interfering RNAs (siRNAs) against JNK1 and JNK2 revealed that JNK1 plays a more important role in GAP-43 phosphorylation in mouse brain ([Figures 3](#fig3){ref-type="fig"}D and 3E), as expected ([@bib21]). JNK is activated in murine developing neurons ([@bib7]). Taken together with our data, this observation suggests that JNK is responsible for the phosphorylation of many GCM proteins with SP/TP sites, such as S96 in GAP-43.

Growing Axons Are Associated with pS96 GAP-43 {#sec2.3}
---------------------------------------------

To further investigate the biological significance of the JNK-dependent, highly P-directed phosphosites in mammalian nerve growth, we focused on pS96 of GAP-43, both because it was the most abundant ([Table S1](#mmc1){ref-type="supplementary-material"}) and because GAP-43 is a classical molecular marker for vertebrate axon growth and regeneration. pS96 Ab recognized exogenously expressed wild-type GAP-43 but not a mutant (S96A) lacking the phosphorylation site, especially under hyperosmotic conditions (0.5 M NaCl), which activate JNK ([Figures S4](#mmc1){ref-type="supplementary-material"}A and S4B) ([@bib58]).

In cultured mouse neurons, this pS96 Ab intensely labeled distal axons and growth cones with a punctate labeling pattern that was particularly concentrated at the growth cone ([Figure 4](#fig4){ref-type="fig"}A). Labeling was much weaker in proximal axons ([Figure 4](#fig4){ref-type="fig"}A) and other minor processes ([Figure 4](#fig4){ref-type="fig"}B). pS96 Ab immunoreactivity in growth cones was distributed along filopodial actin filaments and microtubules in the central domain ([Figures 4](#fig4){ref-type="fig"}C and 4D).Figure 4Antibody Specific for pS96 of GAP-43 Selectively Recognizes Developing and Renewing Axons(A and B) Immunostaining of cultured mouse hippocampal neurons (3 days of culture) using antibodies against pS96 (*green*) and total GAP-43 (*red*). (A) Full view of a single neuron with a long neurite and a growth cone (*arrowhead*). Scale bar: 50 μm. (B) Magnified view of a soma with several neurites. (*Left*) White boxes indicate regions of interest (ROI) that were measured. (*Right*) Means of the staining intensity ratios (pS96 vs pan-GAP-43) in neurites. *N1*: longest neurite; *N2*: second-longest neurite. Scale bar: 10 μm. Values are expressed as means ± SEM; n = 3; \*p \< 0.05.(C and D) Co-localization of pS96 (*green*) with F-actin (*red*) and β-tubulin III (*blue*) in the growth cone of mouse cortical neurons. Scale bar: 5 μm. (C) White box indicates the ROI that was measured. (D) Quantitative distribution of the ROI (C) by measuring the fluorescence intensity along the white dashed line from the filopodial tip. P: peripheral domain; C: central domain.

Immunohistochemical analyses revealed that pS96 Ab specifically recognized growing axons *in vivo* during development ([Figures 5](#fig5){ref-type="fig"}A--5C, [S5](#mmc1){ref-type="supplementary-material"}A, and S5B). On embryonic day (E) 15, GAP-43 itself was expressed in most of the differentiated neurons, whereas by contrast, pS96 was localized to axonal processes but not present in cell bodies ([Figure 5](#fig5){ref-type="fig"}A). pJNK signals partially overlapped with those of pS96 ([Figure 5](#fig5){ref-type="fig"}A). GAP-43 was expressed in most of the differentiated neurons, but *in vivo* immunostaining revealed that pS96 was localized only to axonal processes, not to cell bodies ([Figures 5](#fig5){ref-type="fig"} and [S4](#mmc1){ref-type="supplementary-material"}C--S4F), although in culture, the cell bodies were stained by this Ab ([Figure 4](#fig4){ref-type="fig"}A). In samples co-stained for the cell adhesion molecule L1 and nuclear DNA (with DAPI), GAP-43 itself was expressed by migrating neurons and ingrowing axons in the intermediate zone (IZ), whereas pS96 was restricted to L1-positive thalamocortical axons in the upper IZ. Such axon-specific expression pattern of pS96 was widely distributed in various fiber tracts of the developing brain ([Figure S6](#mmc1){ref-type="supplementary-material"}):Figure 5Expression Pattern of GAP-43, pS96, and pJNK in Developing Mouse Brain(A) Expression in an E15 parasagittal section stained with pan-GAP-43, pS96, and pJNK Abs. GAP-43 itself was expressed in most of the differentiated neurons; by contrast, pS96 was localized to axonal processes but was not detected in cell bodies. pJNK exhibited a broader distribution than GAP-43. OB, olfactory bulb; Cx, neocortex; dTH, dorsal thalamus; MB, midbrain; CB, cerebellum.(B and C) Expression pattern of pS96 and GAP-43 (B) or pS96 and the cell adhesion molecule L1 (C). Nuclear staining with DAPI is also shown. GAP-43 itself was expressed by migrating neurons and ingrowing axons in the intermediate zone (IZ). pS96 expression was restricted to the L1-positive thalamocortical axons in the upper IZ. MZ, marginal zone; CP, cortical plate; VZ, ventricular zone.(D and E) Expression in the primary olfactory system on P14. GAP-43 itself was expressed in the cells of the olfactory epithelium (OE) and the olfactory nerves (ON; D), whereas pS96 was localized only in the ON (E). NC, nasal cavity.Scale bars: 50 μm.

Adult mice contain continuously renewing olfactory axons, and GAP-43-positive cells represent new neurons derived from stem cells in the basal region of the epithelium ([@bib34]). We performed immunohistochemistry using the pS96 Ab to determine whether these regenerating, newly growing axons were stained like the growing axons of developing neurons ([Figures 5](#fig5){ref-type="fig"}D and 5E). In contrast to the conventional pan GAP-43 Ab, the pS96 Ab more precisely detected growing axons and more heavily immunostained nerve bundles and nerves exiting the olfactory epithelium but did not recognize cell bodies ([Figures 5](#fig5){ref-type="fig"}D and 5E).

Taken together, our data show that growing axons *in vivo* were invariably associated with JNK-dependent pS96 of GAP-43, indicating that this Ab represents a new specific molecular marker for growing axons that is superior to anti-pan-GAP-43 Ab.

pS96 Is a Marker for Axon Regeneration in the Peripheral Nervous System {#sec2.4}
-----------------------------------------------------------------------

Peripheral nervous system (PNS) axons in mammals, including humans, can regenerate ([@bib13]). In light of the findings described earlier, we asked whether regenerating PNS axons are associated with pS96 of GAP-43. To answer this question, we generated an injury model of the sciatic nerve in mice. In all the mice used for this regeneration analysis, we confirmed the "Sciatic Functional Index for Mouse" ([@bib36]) before and after the injury ([@bib43]). Three days after the nerve crush, we clearly observed pS96 Ab immunoreactivity ([Figure 6](#fig6){ref-type="fig"}A), suggesting that the pS96-positive axons elongate with time and that they correspond to regenerating neurons after injury. To quantify the regeneration, we calculated the regeneration index, which is the distance from the injury site to the point where the signal intensity drops by half ([@bib44]). The index for pS96 significantly increased on day 3, consistent with that for SCG10 (Stmn2), another marker of axon regeneration ([Figure 6](#fig6){ref-type="fig"}B; [@bib44]). pS96 signals remained low in the intact nerve ([Figure 6](#fig6){ref-type="fig"}A). The "crush" vs "intact" ratio of pS96 signal intensity continuously increased until day 7 ([Figure 6](#fig6){ref-type="fig"}C), whereas that of GAP-43 transiently increased on day 3 and then decreased on day 7 ([Figure 6](#fig6){ref-type="fig"}C), suggesting that pS96 captures axon regeneration more faithfully than GAP-43 itself.Figure 6Axon Regeneration of Injured Sciatic Nerves in Adult Mice Is Strongly Associated with S96 Phosphorylation of GAP-43(A) Immunohistochemistry of longitudinal sections of sciatic nerves at days 1 and 3 after crush injury using pS96, total GAP-43, SCG10, and Tuj-1(neuron-specific β3 tubulin) Abs. SCG10 was used as a positive control for axon regeneration. *Arrowheads* (*white*), injury point; (*black*), the farthest point of positive immunoreactivity. *Intact nerves* indicate immunohistochemistry of uninjured nerves. Note that pS96 Ab did not label *intact nerves*. Scale bars: 500 μm (*days 1 and 3*); 200 μm (*intact*).(B) Regeneration index ([@bib44]) of pS96 (see [Transparent Methods](#mmc1){ref-type="supplementary-material"}) was higher on day 3 than on day 1. n = 4 (day 1), and n = 6 (day 3); \*p \< 0.05, \*\*\*p \< 0.001 by one-way *ANOVA* with Bonferroni tests.(C and D) Quantification of GAP-43 and pS96 on western blots incubated with their specific Abs. Both crushed sciatic nerves and contralateral, intact ones were excised and subjected to blotting using pan-GAP-43 and pS96 Abs on days 1, 3, and 7 after crushing (n = 4 for days 1, 3, and 7). The blot intensities of the proteins in the intact nerve were used as controls. \*p \< 0.05; \*\*\*p \< 0.001 by one-way *ANOVA* with Bonferroni tests. All data in (B--D) are expressed as means ± SD.

Detection of pS96 in Regenerating Axons by Phosphoproteomics of Single Injured Sciatic Nerves {#sec2.5}
---------------------------------------------------------------------------------------------

Next, we tried to detect pS96 by MS. For this purpose, samples likely to include regenerating axons were excised from a single sciatic nerve 3 days after injury. After lysis and electrophoresis ([Figure 7](#fig7){ref-type="fig"}A), the region of the SDS-PAGE gel corresponding to the position of GAP-43 was cut out and analyzed by liquid chromatography (LC)-MS. This approach positively detected pS96 of GAP-43, and in some cases pS142 (see [Figure 3](#fig3){ref-type="fig"}C), another P-directed phosphorylation site of GAP-43 ([Figure 7](#fig7){ref-type="fig"}B). These analyses with small samples sensitively and specifically detected pS96 of GAP-43 in regenerating axons, but not in undamaged axons ([Figure 7](#fig7){ref-type="fig"}B), consistent with the immunohistochemical results ([Figure 6](#fig6){ref-type="fig"}A). By contrast, we could not detect protein kinase C (PKC)-dependent S41 phosphorylation, which had been classically focused on by *in vitro* phosphorylation studies ([@bib46], [@bib2], [@bib11]) ([Figure 7](#fig7){ref-type="fig"}B). Using high-resolution (HR) multiple-reaction monitoring (MRM) for quantification of specific sets of proteins in phosphoproteomics ([Figure S7](#mmc1){ref-type="supplementary-material"}), we confirmed that the level of pS96 GAP-43 was more than 4-fold higher in regenerating axons than in intact nerves ([Figure 7](#fig7){ref-type="fig"}C).Figure 7Phosphoproteomics of a Single, Injured Sciatic Nerve in Adult Mice Reveals that pS96 Is Specifically Detected at Regenerating Axons(A) Schematic of phosphoproteomics procedure for a single injured sciatic nerve. The crushed region of a sciatic nerve was excised and divided into 1 cm segments, which were prepared for SDS-PAGE. The band corresponding to GAP-43 was cut out, trypsinized in-gel, and subjected to MS analysis. \*, molecular mass marker.(B) Shotgun phosphoproteomics analysis of a single crushed nerve. Note that pS96 was detected in three of five injured samples, and another JNK-dependent site, pS142 ([Figure 3](#fig3){ref-type="fig"}C), was also detected twice. By contrast, no phosphorylated peptides of GAP-43 were detected in intact nerves.(C) MS quantification of pS96 using HR-MRM to compare crushed (*Crush*) and intact sciatic nerves on day 3 after injury. *Crush* represents the regenerating axons. \*\*p \< 0.01 (Student\'s t test). All data are shown as means ± SD.

These results indicate that pS96 of GAP-43 is tightly associated with PNS axon regeneration and involved in the functional recovery that accompanies regeneration. In addition, these findings confirm that pS96 Ab is a promising molecular marker for regenerating axons, as well as those growing during normal development.

Discussion {#sec3}
==========

In this study, we performed quantitative profiling of phosphoproteins and their phosphorylation sites in mammalian GCMs. We obtained three important results: (1) The high frequency of P-directed phosphorylation in GCMs ([Figures 2](#fig2){ref-type="fig"}A and 2B; [Table S1](#mmc1){ref-type="supplementary-material"}), as revealed by bioinformatics and biological experiments, was primarily due to MAPKs ([Figure 2](#fig2){ref-type="fig"}C), and in particular JNK ([Figure 3](#fig3){ref-type="fig"}). (2) The most abundant phosphorylated site, S96 of GAP-43 ([Table S1](#mmc1){ref-type="supplementary-material"}), also underwent JNK-dependent phosphorylation ([Figure 3](#fig3){ref-type="fig"}). In addition (3), pS96 was tightly associated with both developmental axon growth ([Figures 4](#fig4){ref-type="fig"}, [5](#fig5){ref-type="fig"}, [S5](#mmc1){ref-type="supplementary-material"}, and [S6](#mmc1){ref-type="supplementary-material"}) and axon regeneration ([Figures 6](#fig6){ref-type="fig"} and [7](#fig7){ref-type="fig"}).

Our results suggest that mammalian nerve growth requires activation of JNK. Surprisingly, this conclusion is essentially consistent with the requirement for JNK signaling in axon regeneration, consistent with the results of a large number of mutant screens in *C. elegans* ([@bib19], [@bib56], [@bib8], [@bib1]). We conclude that JNK signaling is evolutionarily conserved, even in mammalian axon growth, as demonstrated by the large number of substrates that depend on P-directed kinases. Although S96 phosphorylation was discovered using classical methodology more than a quarter century ago ([@bib47]), this was before the discovery of JNK ([@bib20]); however, there have been no reports showing a link between pS96 and JNK to date. We also demonstrated that JNK supports axon growth by modulating vertebrate-specific substrates such as GAP-43 ([Figure 3](#fig3){ref-type="fig"}) during mammalian development ([@bib22]). Although pS96 was found within the supplemental large datasets of the adult mouse brain phosphoproteomics ([@bib28], [@bib32]), its functions in adult brain is not known.

Our results show that pS96 of GAP-43 is associated with normal mammalian axon growth ([Figures 4](#fig4){ref-type="fig"} and [5](#fig5){ref-type="fig"}) and regeneration ([Figures 6](#fig6){ref-type="fig"} and [7](#fig7){ref-type="fig"}), probably because it is the best substrate for JNK ([Table S1](#mmc1){ref-type="supplementary-material"}). Therefore, the pS96 Ab represents a promising marker for growing and regenerating axons in rodents. Previously, we reported that pS96 Ab could be involved in the regeneration of nerves after surgery ([@bib42]); however, at that time, the importance of pS96 was not clearly understood. Here, the proteomic results ([Figures 2](#fig2){ref-type="fig"} and [3](#fig3){ref-type="fig"}; [Table S1](#mmc1){ref-type="supplementary-material"}) provide a background against which to understand the importance of this phosphorylation. In addition, pS96 could be detected by MS at high levels, even in a single regenerating segment of injured PNS axons ([Figures 7](#fig7){ref-type="fig"}B and 7C). Considering that GAP-43 itself was widely distributed throughout the cell bodies of the developing neurons ([Figures 5](#fig5){ref-type="fig"}A--5C) and was present in the intact mature neurons ([Figure 6](#fig6){ref-type="fig"}A), pS96 could be used as a strong and specific marker for axon growth and regeneration in rodents. We recently succeeded in performing super-resolution microscopy of the behaviors of live growth cones, revealing new endocytic mechanisms for nerve growth ([@bib39], [@bib38]). This new method should help reveal the function of pS96 signaling in growth cone behavior much more precisely.

It is important to note that JNK is also a negative regulator of axon growth and can induce axon degeneration ([@bib35], [@bib49], [@bib31], [@bib57]). Accordingly, based on all available data, we conclude that JNK physiologically contributes to axon growth ([@bib54]). The ability to control JNK activity in the near future may lead to effective axon regeneration, enabling clinical treatment of intractable neurological diseases and neural injuries.

Methods {#sec4}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.

Supplemental Information {#appsec2}
========================

Document S1. Transparent Methods, Figures S1--S7, and Tables S1--S5Data S1. Phosphoproteomics of the GCM Proteins, Related to Figure 1A: Time; B: Precise molecular weight; C: Precise m/z; D: Precise charge (z); E: Protein number (see Data S2); F: Best sequence; G: Modification; H: Confidence; I: Theoretical mass; J: Charge (z).Data S2. Identified GCM Proteins Analyzed with Phosphoproteomics, Related to Figure 1A: Protein number (see Data S1); B: Unused; C: Total; D: % coverage; E: Accession number; F: Protein name. *Yellow line*: no phosphorylation-modified peptides were found (only other modifications such as methylation, etc.); *Red line:* no phosphopeptides with \>95% reliability were found. They have been deleted from the total counts (Figure 1).Data S3. Enrichment Analysis of the GCM Phosphoproteins, Related to Figure 2*Category*, KEGG BRITE categories were used for enrichment analysis. The number of enriched genes was counted in the fourth level of the categories. If the number of genes included in a category is lower than four, the category is removed from the calculation. p*-value*, p-value of Fisher\'s exact test; *Q-value*, FDR adjusted p-value; *Genes*, the genes encoding the identified phosphoproteins in GCM. See also Figure 2D.
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